Literature DB >> 17530478

Relative quantification of immune-regulatory genes in two rainbow trout strains, Oncorhynchus mykiss, after exposure to Myxobolus cerebralis, the causative agent of whirling disease.

Vanessa I C Severin1, Mansour El-Matbouli.   

Abstract

Expression of immune-regulatory genes that code for cyclooxigenase-2 (COX-2), transforming growth factor beta (TGF-beta), and two isoforms of interleukin-1beta (IL-1beta1 and IL-1beta2) was studied in susceptible and non-susceptible rainbow trout strains for 200 days after exposure to Myxobolus cerebralis. Expression of COX-2, IL-1beta1, and IL-1beta2 increased 5 min post exposure (p.e.) and was always more elevated in the susceptible strain than in the non-susceptible strain. In both strains, expression of COX-2 returned to the control level within a few hours p.e. Expression of IL-1beta1 and IL-1beta2 showed two elevated waves in both strains until 4 days p.e. Expression of TGF-beta in the non-susceptible strain was elevated at nearly all sampling points, but was decreased in the susceptible strain until up-regulation between 4 and 20 days p.e.; TGF-beta was the only gene where the expression in the non-susceptible strain was more elevated than in the susceptible strain. Rainbow trout of the non-susceptible strain appeared to resist infection by M. cerebralis with only minor transcriptional regulation of the genes investigated. Increased transcriptions of genes in the susceptible strain may be the result of an inability to antagonize the infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17530478     DOI: 10.1007/s00436-007-0582-z

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  40 in total

1.  Biology contravenes taxonomy in the myxozoa: new discoveries show alternation of invertebrate and vertebrate hosts.

Authors:  K Wolf; M E Markiw
Journal:  Science       Date:  1984-09-28       Impact factor: 47.728

2.  Molecular and functional characterization of a fish inducible-type nitric oxide synthase.

Authors:  J P Saeij; R J Stet; A Groeneveld; L B Verburg-van Kemenade; W B van Muiswinkel; G F Wiegertjes
Journal:  Immunogenetics       Date:  2000-04       Impact factor: 2.846

3.  Comparative susceptibility of rainbow trout Oncorhynchus mykiss and brown trout Salmo trutta to Myxobolus cerebralis, the cause of salmonid whirling disease.

Authors:  R P Hedrick; T S McDowell; M Gay; G D Marty; M P Georgiadis; E MacConnell
Journal:  Dis Aquat Organ       Date:  1999-09-14       Impact factor: 1.802

4.  The expression of immune-regulatory genes in rainbow trout, Oncorhynchus mykiss, during amoebic gill disease (AGD).

Authors:  Andrew R Bridle; Richard N Morrison; Barbara F Nowak
Journal:  Fish Shellfish Immunol       Date:  2006-03       Impact factor: 4.581

5.  Host responses to Renibacterium salmoninarum and specific components of the pathogen reveal the mechanisms of immune suppression and activation.

Authors:  T Hilton Grayson; Lynne F Cooper; Annette B Wrathmell; Janet Roper; Andrew J Evenden; Martyn L Gilpin
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

6.  Pathogenesis and inflammatory response to Edwardsiella tarda infection in the zebrafish.

Authors:  Meagan E Pressley; Peter E Phelan; P Eckhard Witten; Mark T Mellon; Carol H Kim
Journal:  Dev Comp Immunol       Date:  2004-12-24       Impact factor: 3.636

7.  The expression of immune-regulatory genes in rainbow trout, Oncorhynchus mykiss, during a natural outbreak of proliferative kidney disease (PKD).

Authors:  J W Holland; C R W Gould; C S Jones; L R Noble; C J Secombes
Journal:  Parasitology       Date:  2003       Impact factor: 3.234

8.  Lepeophtheirus salmonis: characterization of prostaglandin E(2) in secretory products of the salmon louse by RP-HPLC and mass spectrometry.

Authors:  M D Fast; N W Ross; C A Craft; S J Locke; S L MacKinnon; S C Johnson
Journal:  Exp Parasitol       Date:  2004 May-Jun       Impact factor: 2.011

9.  Ontogeny and behaviour of early macrophages in the zebrafish embryo.

Authors:  P Herbomel; B Thisse; C Thisse
Journal:  Development       Date:  1999-09       Impact factor: 6.868

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  5 in total

1.  A major effect quantitative trait locus for whirling disease resistance identified in rainbow trout (Oncorhynchus mykiss).

Authors:  M R Baerwald; J L Petersen; R P Hedrick; G J Schisler; B May
Journal:  Heredity (Edinb)       Date:  2010-11-03       Impact factor: 3.821

2.  Dietary vegetable oils do not alter the intestine transcriptome of gilthead sea bream (Sparus aurata), but modulate the transcriptomic response to infection with Enteromyxum leei.

Authors:  Josep A Calduch-Giner; Ariadna Sitjà-Bobadilla; Grace C Davey; Michael T Cairns; Sadasivam Kaushik; Jaume Pérez-Sánchez
Journal:  BMC Genomics       Date:  2012-09-11       Impact factor: 3.969

3.  Discovery of genes implicated in whirling disease infection and resistance in rainbow trout using genome-wide expression profiling.

Authors:  Melinda R Baerwald; Amy B Welsh; Ronald P Hedrick; Bernie May
Journal:  BMC Genomics       Date:  2008-01-24       Impact factor: 3.969

4.  Immune gene expression profiling of Proliferative Kidney Disease in rainbow trout Oncorhynchus mykiss reveals a dominance of anti-inflammatory, antibody and T helper cell-like activities.

Authors:  Bartolomeo Gorgoglione; Tiehui Wang; Christopher J Secombes; Jason W Holland
Journal:  Vet Res       Date:  2013-07-16       Impact factor: 3.683

5.  STAT3/SOCS3 axis contributes to the outcome of salmonid whirling disease.

Authors:  Mona Saleh; Adina Friedl; Mitaly Srivastava; Hatem Soliman; Christopher J Secombes; Mansour El-Matbouli
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.